Recent News

• 04.01.2025 - Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
• 04.01.2025 - Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
• 02.27.2025 - Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress
• 02.27.2025 - Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress
• 02.18.2025 - Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
• 02.18.2025 - Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
• 02.12.2025 - February 12, 2025 2:40 PM EST - February 12, 2025 3:10 PM EST : Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.12.2025 - February 12, 2025 2:40 PM EST - February 12, 2025 3:10 PM EST : Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.05.2025 - Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.05.2025 - Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Recent Filings

• 03.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.12.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 02.28.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.10.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors